Literature DB >> 25893477

The kidney in obesity.

Josep Redon1, Empar Lurbe.   

Abstract

Body mass index has been found to be the second most important contributor to relative risk for developing end state renal disease (ESRD), after proteinuria. The impact of obesity on the kidney includes a wide spectrum, from characteristic pathologic lesions to increment in urinary albumin excretion (UAE) and proteinuria/or decrease in glomerular filtration rate (GFR). The cause of renal disease associated to obesity is not well understood, but two relevant elements emerge. The first is the presence of obesity-related glomerulopathy, and the second is the fat deposit in the kidney with impact on renal haemodynamics and intrarenal regulation. The mechanisms linking obesity and renal damage are complex and include haemodynamic changes, inflammation, oxidative stress, apoptosis, and finally renal scarring. The protection of kidney damage needs to combine weight reduction with the proper control of the cardiometabolic risk factors associated, hypertension, metabolic syndrome, diabetes and dyslipidaemia. The search for specific treatments merits future research.

Entities:  

Mesh:

Year:  2015        PMID: 25893477     DOI: 10.1007/s11906-015-0555-z

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  95 in total

1.  Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Leonelo Bautista; Maria Grazia Franzosi; Patrick Commerford; Chim C Lang; Zvonko Rumboldt; Churchill L Onen; Liu Lisheng; Supachai Tanomsup; Paul Wangai; Fahad Razak; Arya M Sharma; Sonia S Anand
Journal:  Lancet       Date:  2005-11-05       Impact factor: 79.321

2.  A prospective study of body mass index, weight change, and risk of stroke in women.

Authors:  K M Rexrode; C H Hennekens; W C Willett; G A Colditz; M J Stampfer; J W Rich-Edwards; F E Speizer; J E Manson
Journal:  JAMA       Date:  1997-05-21       Impact factor: 56.272

3.  Body mass index and the risk of development of end-stage renal disease in a screened cohort.

Authors:  Kunitoshi Iseki; Yoshiharu Ikemiya; Kozen Kinjo; Taku Inoue; Chiho Iseki; Shuichi Takishita
Journal:  Kidney Int       Date:  2004-05       Impact factor: 10.612

4.  Measures of obesity and cardiovascular risk among men and women.

Authors:  Rebecca P Gelber; J Michael Gaziano; E John Orav; Joann E Manson; Julie E Buring; Tobias Kurth
Journal:  J Am Coll Cardiol       Date:  2008-08-19       Impact factor: 24.094

5.  The effects of weight loss on renal function in patients with severe obesity.

Authors:  Avry Chagnac; Tali Weinstein; Michal Herman; Judith Hirsh; Uzi Gafter; Yaacov Ori
Journal:  J Am Soc Nephrol       Date:  2003-06       Impact factor: 10.121

6.  Prognostic value of microalbuminuria during antihypertensive treatment in essential hypertension.

Authors:  Jose Maria Pascual; Enrique Rodilla; Jose Antonio Costa; Miguel Garcia-Escrich; Carmen Gonzalez; Josep Redon
Journal:  Hypertension       Date:  2014-09-22       Impact factor: 10.190

7.  Acetaminophen attenuates obesity-related renal injury through ER-mediated stress mechanisms.

Authors:  Cuifen Wang; Miaozong Wu; Ravikumar Arvapalli; Xiaoniu Dai; Muhammad Mahmood; Henry Driscoll; Kevin M Rice; Eric Blough
Journal:  Cell Physiol Biochem       Date:  2014-04-11

Review 8.  Obesity, oxidative stress, and fibrosis in chronic kidney disease.

Authors:  Kumar Sharma
Journal:  Kidney Int Suppl (2011)       Date:  2014-11

Review 9.  Relationship between chronic kidney disease and metabolic syndrome: current perspectives.

Authors:  Khaled Nashar; Brent M Egan
Journal:  Diabetes Metab Syndr Obes       Date:  2014-09-18       Impact factor: 3.168

Review 10.  Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis.

Authors:  Giovanni Musso; Roberto Gambino; James H Tabibian; Mattias Ekstedt; Stergios Kechagias; Masahide Hamaguchi; Rolf Hultcrantz; Hannes Hagström; Seung Kew Yoon; Phunchai Charatcharoenwitthaya; Jacob George; Francisco Barrera; Svanhildur Hafliðadóttir; Einar Stefan Björnsson; Matthew J Armstrong; Laurence J Hopkins; Xin Gao; Sven Francque; An Verrijken; Yusuf Yilmaz; Keith D Lindor; Michael Charlton; Robin Haring; Markus M Lerch; Rainer Rettig; Henry Völzke; Seungho Ryu; Guolin Li; Linda L Wong; Mariana Machado; Helena Cortez-Pinto; Kohichiroh Yasui; Maurizio Cassader
Journal:  PLoS Med       Date:  2014-07-22       Impact factor: 11.069

View more
  9 in total

Review 1.  Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment.

Authors:  Tianhua Xu; Zitong Sheng; Li Yao
Journal:  Front Med       Date:  2017-08-08       Impact factor: 4.592

2.  Transcriptional and Translational Modulation of myo-Inositol Oxygenase (Miox) by Fatty Acids: IMPLICATIONS IN RENAL TUBULAR INJURY INDUCED IN OBESITY AND DIABETES.

Authors:  Tatsuya Tominaga; Rajesh K Dutta; Darukeshwara Joladarashi; Toshio Doi; Janardan K Reddy; Yashpal S Kanwar
Journal:  J Biol Chem       Date:  2015-11-17       Impact factor: 5.157

3.  Differential Effect of Sucrose and Fructose in Combination with a High Fat Diet on Intestinal Microbiota and Kidney Oxidative Stress.

Authors:  Adriana Rosas-Villegas; Mónica Sánchez-Tapia; Azalia Avila-Nava; Victoria Ramírez; Armando R Tovar; Nimbe Torres
Journal:  Nutrients       Date:  2017-04-16       Impact factor: 5.717

4.  Precocious obesity predisposes the development of more severe cisplatin-induced acute kidney injury in young adult mice.

Authors:  Rosemara S Ribeiro; Clevia S Passos; Antônio S Novaes; Edgar Maquigussa; Maria A Glória; Iria Visoná; Olinda Ykuta; Lila M Oyama; Mirian A Boim
Journal:  PLoS One       Date:  2017-03-30       Impact factor: 3.240

5.  Salvianolic Acid B Protects Against Fatty Acid-Induced Renal Tubular Injury via Inhibition of Endoplasmic Reticulum Stress.

Authors:  Xiaoyi Mai; Xin Yin; Peipei Chen; Minzhou Zhang
Journal:  Front Pharmacol       Date:  2020-12-15       Impact factor: 5.810

Review 6.  Impact of Obesity in Kidney Diseases.

Authors:  Vasilios Kotsis; Fernando Martinez; Christina Trakatelli; Josep Redon
Journal:  Nutrients       Date:  2021-12-15       Impact factor: 5.717

7.  Blockade of myeloid differentiation protein 2 prevents obesity-induced inflammation and nephropathy.

Authors:  Qilu Fang; Lintao Wang; Daona Yang; Xiong Chen; Xiaoou Shan; Yali Zhang; Hazel Lum; Jingying Wang; Peng Zhong; Guang Liang; Yi Wang
Journal:  J Cell Mol Med       Date:  2017-08-02       Impact factor: 5.310

8.  Long-term risk for end-stage kidney disease and death in a large population-based cohort.

Authors:  Emanuel Zitt; Constanze Pscheidt; Hans Concin; Reinhard Kramar; Raphael S Peter; Jan Beyersmann; Karl Lhotta; Gabriele Nagel
Journal:  Sci Rep       Date:  2018-05-16       Impact factor: 4.379

9.  Impact of a Community-Based Weight Loss Program on Renal Function.

Authors:  Tiffany E Schwasinger-Schmidt; Georges Elhomsy; Bobbie G Paull-Forney
Journal:  Cureus       Date:  2020-05-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.